All Submitted Abstracts

• It is preferred that ASM Microbe 2023 be the first major presentation of the abstract.
• A presenter may be a presenter on more than 1 abstract.
• Programming decisions are considered final.
• Abstracts must be well written and easy to understand.
• Approval of all co-authors must be obtained before placing their names on an abstract.
• Submission of multiple overlapping abstracts is discouraged.

Clinical Tracks (AAR, CPHM, CIV, POM) 

• The reason for the study, or how the study came about, (e.g. hypothesis, discovery or central question) should be clearly stated.
• Methods must be included.
• Data must be objectively gathered, analyzed and reported.
• Data must support the stated conclusion(s).
• All presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-US IND or non-US early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s to describe new compounds and their properties, and that chemical structures of lead compounds will be included as part of the poster presentation). 
  • Please note: Any posters or talks dealing with a specific small molecule antimicrobial agent must provide a chemical structure, or a literature reference to the structure, in order to be presented at the meeting. Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.

• Scientific presentations at ASM Microbe 2023 will be expected to transparently report a study’s scientific rigor, including but, not limited to the following: 1) experimental design; 2) methodology; 3) data collection; 4) analysis and 5) interpretation and report of results. Other key components of scientific rigor included, if applicable, are sample size, randomization, blinding, and replication.

Basic Science Tracks (AES, EEB, HMB, MBP)

• The reason for the study or how the study came about, (e.g. hypothesis, discovery or central question) should be clearly stated.
• Data must be objectively gathered, analyzed and reported.
• Data must support the stated conclusion(s).
• Conclusion(s) should be made but, the study does not need to be fully complete (the standard to present at Microbe is not the same as to publish in a journal).
• Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.
• Scientific presentations at ASM Microbe 2023 will be expected to transparently report a study’s scientific rigor, including, but not limited to the following: 1) experimental design and 2) interpretation and report of results.

ASM Members

Premium | $965.00
Contributing | $1,055.00
Medical Lab Specialist | $1,055.00
Supporting | $1,420.00
Global Outreach | $1,055.00
Honorary | $1,055.00
Emeritus | $520.00
Student Poster Presenter | $520.00
Postdoc | $685.00
Postdoc Global Outreach | $685.00
Student | $520.00
Student Global Outreach | $520.00

Non-Members

Invited Speaker | $340.00
Non-Member | $1,420.00
Postdoc | $925.00
Student | $710.00
Non-Exhibiting Supplier | $1,575.00
Exhibitor Booth Personnel | $160.00